⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

May 28, 2024

[A multicenter study on the accuracy of PAX1/JAM3 dual genes methylation testing for screening cervical cancer].

Xiao Shang Lijuan Kong Xing Xiao Runtian Wan Jianping Wang Huanwen Wu X Y Chen H F Shou J Fei Jianwei Zhou Jing-He Lang Li Li

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

To explore the value of cervical cytologic DNA methylation for screening cervical cancer.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Shang et al. (2024) studied this question.

synapsesocial.com/papers/68e680f4b6db643587609d7d https://doi.org/10.3760/cma.j.cn12137-20231004-00630

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

114P Evaluation of PAX1/JAM3 gene methylation detection for cervical cancer screening: A prospective multi-center study2024
2Triage performance of PAX1m/JAM3m in opportunistic cervical cancer screening of non‒16/18 human papillomavirus-positive women: a multicenter prospective study in China2024 · 21 citations
3Effectiveness analysis and clinical application potential exploration of combined detection of PAX1/JAM3 gene methylation in early diagnosis of cervical precancerous lesionsOriginal Research · 2026 · 1 citations
4Diagnostic performance of PAX1 methylation as a biomarker for cervical lesions: a clinical study and meta-analysis2025
5Utility of <i>PAX1</i> / <i>JAM3</i> methylation analysis for triage of high-risk HPV-positive individualsOriginal Research · 2026